This inventor holds 4 USPTO granted patents. Top assignees: The Salk Institute, Chichibu Cement Co., Ltd., Chichibu Onoda Cement Corp.. Active years: 1991-1997.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Ibaraki, JP (1991 - 1995)
- Tsukuba, JP (1997)
Company Filing History:

Years Active: 1991-1997
Title: Naoto Ueno: Innovator in Bone Morphogenetic Proteins
Introduction
Naoto Ueno is a prominent inventor based in Ibaraki, Japan, known for his significant contributions to the field of biological studies. He holds a total of four patents, focusing primarily on bone morphogenetic proteins and their applications in medical science.
Latest Patents
Ueno's latest patents include groundbreaking work on DNA encoding bone morphogenetic proteins and host cells transformed to produce these proteins. His inventions disclose a Xenopus laevis bone morphogenetic protein (BMP), a DNA segment coding for this BMP, and a method for preparing the BMP through culturing transformed cells. These innovations allow for the production of large amounts of mature peptides that promote the synthesis of proteoglycan. This research has potential applications in understanding human bone-cartilage morphogenetic reactions and developing therapeutic agents for osteoporosis.
Career Highlights
Throughout his career, Naoto Ueno has worked with esteemed organizations such as the Salk Institute for Biological Studies and Chichibu Cement Co., Ltd. His work has significantly advanced the understanding of bone morphogenetic proteins and their therapeutic potential.
Collaborations
Ueno has collaborated with notable colleagues, including Nicholas C. Ling and Shunichi Shimasaki, contributing to the advancement of research in his field.
Conclusion
Naoto Ueno's innovative work in the field of bone morphogenetic proteins has made a lasting impact on medical research and potential therapies for osteoporosis. His contributions continue to influence the scientific community and pave the way for future advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile